|
|
|
|
|
Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation
|
|
Shinoda M., Ebinuma H., Itano O., Yamagishi Y., Obara H., Kitago M., Nakamoto N., Hibi T., Yagi H., Abe Y., Matsubara K., Chu P., Wakayama Y., Taniki N., Yamaguchi A., Amemiya R., Miyake R., Mizota T., Kanai T., Kitagawa Y. Hepatology Research. 2016;4611:1118-1128.
|
|
|
|
|
|
|
|